Cart

Remove item Thumbnail image Product Price Quantity Subtotal
× Get comprehensive AFG3L2 Gene Spinocerebellar Ataxia Type 28 autosomal dominant NGS genetic DNA testing for $500 USD in USA. Early detection of hereditary neurological disorders through advanced next-generation sequencing technology. Available in major cities including New York AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test $500
$500

Cart totals

Subtotal $500
Total $500

Certified & Accredited

Our laboratory meets international standards—ISO certified—ensuring hospitals receive trusted, high-quality genetic results.

Clinical Precision

We use advanced sequencing technology for accurate DNA and genetic testing, supporting doctors in delivering reliable diagnoses and personalized patient care.

Rapid Turnaround

Get test results in as little as short time as possible, helping hospitals make fast, informed treatment decisions.

Expert Support

Hospital teams get direct access to our certified genetic counselors and technical experts for seamless, professional collaboration and guidance.